Edwards Lifesciences Lunch Symposia

Edwards Lifesciences Symposia

Explore cutting-edge topics at our two lunch symposia. Gain insights from leading experts and engage in impactful discussions. Be sure to check out the full agenda below and save the dates in your calendar!

Thursday 09 Oct 2025

Thursday 09 Oct 2025 | 09:00 - 18:30 |

A new horizon in aortic root disease management

Explore the latest in aortic root disease management, from surgical innovations like Valsalva vs. straight conduits to the integration of new technologies and pre-assembled valved conduits. Gain practical insights to enhance outcomes in this evolving field.

Moderators: Ruggero De PaulisItaly.

Aortic Valve Replacement

Gianluca Lucchese
Gianluca Lucchese
USA

Trans-Axillary Mitral Surgery

Marco Di Eusanio
Marco Di Eusanio
Italy

Endoscopic Mitral Repair

Antonio Pitsis
Antonio Pitsis
Greece

Bentall Procedure with a Novel Valved Conduit

Ruggero De Paulis
Ruggero De Paulis
Italy

Friday 10 Oct 2025

Lifetime Management in Light of the 2025 ESC/EACTS Guidelines

Explore how the new guidelines are redefining lifetime management of heart valve disease. This symposium offers practical insights into next-gen bioprosthesis, durable treatment strategies, and real-world case discussions to support long-term patient care.

Moderators: Christian CarranzaDenmark and Michael BorgerGermany.

Bentall Procedure with a Novel Valved Conduit

Malakh Shrestha
Malakh Shrestha
USA
Gregory Fontana
Gregory Fontana
USA

Aortic Valve Replacement

Piotr Suwalski
Piotr Suwalski
Poland

Aortic Root Enlargement Wet Lab

Bo Yang
Bo Yang
USA

Warning: Undefined array key "type" in /var/www/html/wp-content/themes/theme-eacts/php/components/partials/btn.php on line 9
Previous
Warning: Undefined array key "type" in /var/www/html/wp-content/themes/theme-eacts/php/components/partials/btn.php on line 9
Next

Seeking continuous learning?

Download Edwards Masters App.

A professional digital education platform for cardio-thoracic surgeons. Your go-to resource for staying at the forefront.

†Consult instructions for use for device preparation instructions
*Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.

Reference:
1. Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791.

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).